Beyond Air receives CE Mark for LungFit PH in Europe; triggers $1M milestone payment from Getz Healthcare

Beyond Air, Inc.

CE mark approval allows Beyond Air to market LungFit PH in the European Union and other recognizing countries.
$1 million milestone payment triggered from Asia-Pacific partner Getz Healthcare upon CE mark certification.
Indications include hypoxic respiratory failure in infants >34 weeks gestation and peri-/post-operative pulmonary hypertension in adults and children 0-17.
Partnership with Getz covers Australia, New Zealand, Thailand, Philippines, Taiwan, Hong Kong, Malaysia, Pakistan, Singapore, and Vietnam.
LungFit PH generates NO from ambient air via Ionizer technology, eliminating tanks and reducing hospital carbon footprint.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.